Michael A Metzger Cti Biopharma Corp (CTIC) insider trading activity

Michael A Metzger is Director of CTI BIOPHARMA CORP. Currently has a direct ownership of 0 shares of CTIC, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2022, when has been sold 91,500 shares (Common Stock) at a price of $5.63 per share, resulting in proceeds of $515,145. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Michael A Metzger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2022	SELL Open market or private sale	$515,145 $5.63 p/Share	91,500 Reduced 100.0%	0 Common Stock
Nov 08 2022	BUY Exercise of conversion of derivative security	$84,180 $0.92 p/Share	91,500 Added 50.0%	91,500 Common Stock
Jul 07 2022	SELL Open market or private sale	$131,390 $6.53 p/Share	20,121 Reduced 100.0%	0 Common Stock
Jul 05 2022	SELL Open market or private sale	$558,150 $6.1 p/Share	91,500 Reduced 81.97%	20,121 Common Stock
Jul 05 2022	BUY Exercise of conversion of derivative security	$76,860 $0.84 p/Share	91,500 Added 45.05%	111,621 Common Stock

Also insider at

SNDX

Syndax Pharmaceuticals Inc Healthcare

Chief Executive Officer

PYXS

Pyxis Oncology, Inc. Healthcare

MAM